PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SWAV vs. NVDA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SWAV and NVDA is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

SWAV vs. NVDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ShockWave Medical, Inc. (SWAV) and NVIDIA Corporation (NVDA). The values are adjusted to include any dividend payments, if applicable.

500.00%1,000.00%1,500.00%2,000.00%2,500.00%3,000.00%3,500.00%4,000.00%JulyAugustSeptemberOctoberNovemberDecember
997.54%
3,535.04%
SWAV
NVDA

Key characteristics

Fundamentals

Market Cap

SWAV:

$12.57B

NVDA:

$3.19T

EPS

SWAV:

$4.25

NVDA:

$2.53

PE Ratio

SWAV:

78.76

NVDA:

51.54

Total Revenue (TTM)

SWAV:

$421.78M

NVDA:

$113.27B

Gross Profit (TTM)

SWAV:

$368.26M

NVDA:

$85.93B

EBITDA (TTM)

SWAV:

$103.71M

NVDA:

$74.87B

Returns By Period


SWAV

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

NVDA

YTD

172.06%

1M

-7.66%

6M

6.44%

1Y

175.01%

5Y*

86.75%

10Y*

75.35%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SWAV vs. NVDA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ShockWave Medical, Inc. (SWAV) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SWAV, currently valued at 3.63, compared to the broader market-4.00-2.000.002.003.633.44
The chart of Sortino ratio for SWAV, currently valued at 7.97, compared to the broader market-4.00-2.000.002.004.007.973.64
The chart of Omega ratio for SWAV, currently valued at 2.82, compared to the broader market0.501.001.502.002.821.46
The chart of Calmar ratio for SWAV, currently valued at 2.02, compared to the broader market0.002.004.006.002.026.66
The chart of Martin ratio for SWAV, currently valued at 69.01, compared to the broader market-5.000.005.0010.0015.0020.0025.0069.0120.59
SWAV
NVDA


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.00JulyAugustSeptemberOctoberNovemberDecember
3.63
3.44
SWAV
NVDA

Dividends

SWAV vs. NVDA - Dividend Comparison

SWAV has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.02%.


TTM20232022202120202019201820172016201520142013
SWAV
ShockWave Medical, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVDA
NVIDIA Corporation
0.02%0.03%0.11%0.05%0.12%0.27%0.46%0.29%0.45%1.20%1.70%1.94%

Drawdowns

SWAV vs. NVDA - Drawdown Comparison


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-0.02%
-9.52%
SWAV
NVDA

Volatility

SWAV vs. NVDA - Volatility Comparison

The current volatility for ShockWave Medical, Inc. (SWAV) is 0.00%, while NVIDIA Corporation (NVDA) has a volatility of 10.07%. This indicates that SWAV experiences smaller price fluctuations and is considered to be less risky than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%JulyAugustSeptemberOctoberNovemberDecember0
10.07%
SWAV
NVDA

Financials

SWAV vs. NVDA - Financials Comparison

This section allows you to compare key financial metrics between ShockWave Medical, Inc. and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab